Author`s name AP ©

Shareholders approve of Shire's purchase

Shareholders approve of Shire's purchase
Shareholders approve of Shire's purchase

Pharmaceutical maker Shire PLC announced that its shareholders approved the proposed acquisition of New River Pharmaceuticals Inc.

Shire offered US$64 (47.32 EUR) per share, or approximately US$2.6 billion (1.92 billion EUR), for New River in February.

"Consummation of the tender offer now remains subject only to certain customary conditions," the company said in a statement.

The tender offer will expire on Tuesday.

Shire shares gained 0.1 percent to 64.28 pence (US$1.27; 0.94 EUR) on the London Stock Exchange.